Pete has 25 years of technical operations experience in bringing new pharmaceutical products to the global marketplace, with specific experience in formulation development, process development, scale-up, technology transfer, and validation for both sterile and nonsterile products. He has held positions of increasing seniority at both large pharmaceutical and biotechnology companies, including serving most recently as vice president, global pharmaceutical sciences, at NPS Pharmaceuticals, Inc., which was acquired by Shire. Previously he served as senior director, pharmaceutical sciences quality, and also headed one of the product development groups at Schering-Plough Research Institute.   Pete has 25 years of technical operations experience in bringing new pharmaceutical products to the global marketplace, with specific experience in formulation development, process development, scale-up, technology transfer, and validation for both sterile and nonsterile products. He has held positions of increasing seniority at both large pharmaceutical and biotechnology companies, including serving most recently as vice president, global pharmaceutical sciences, at NPS Pharmaceuticals, Inc., which was acquired by Shire. Previously he served as senior director, pharmaceutical sciences quality, and also headed one of the product development groups at Schering-Plough Research Institute.

General Science